NovAccess Global Inc. Stock Other OTC
Equities
XSNX
US67001N1072
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.17M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -4M | EV / Sales 2022 | - |
Net Debt 2022 | 1.41M | Net Debt 2023 | 2.36M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.16
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 20-10-14 | |
Neil Laird
DFI | Director of Finance/CFO | 70 | 21-09-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 20-10-14 | |
Jason Anderson
BRD | Director/Board Member | 50 | 22-03-17 |
John Cassarini
CHM | Chairman | 57 | 22-03-13 |
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.36B | |
+44.25% | 41.3B | |
+2.56% | 39.61B | |
-12.11% | 25.62B | |
+3.09% | 24.09B | |
-24.16% | 18.38B | |
+22.12% | 11.85B | |
-3.74% | 11.82B | |
+7.75% | 11.07B |